NCT01473069View on ClinicalTrials.gov

Two Week Study Evaluating Safety, Tolerability and Pharmacokinetics of Multiple Doses of JTK-853 in Healthy Subjects

PHASE1TerminatedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Healthy
Interventions
DRUG

JTK-853, ketoconazole

JTK-853 Tablets or Placebo, twice a day for 14 days, JTK-853 and ketoconazole Tablets, 1 each on Day 15

DRUG

JTK-853 or Placebo

JTK-853 Tablets or Placebo, twice a day for 14 days

Trial Locations (1)

78744

PPD Phase I Clinic, Austin

Sponsors

Lead Sponsor

Akros Pharma Inc.
All Listed Sponsors
lead

Akros Pharma Inc.

INDUSTRY

NCT01473069 - Two Week Study Evaluating Safety, Tolerability and Pharmacokinetics of Multiple Doses of JTK-853 in Healthy Subjects | Biotech Hunter | Biotech Hunter